Study on the Impact of Depression on the Quality of Life of Patients With Psoriasis

Roxana-Cristina Oltenacu, Gabriela Stoleriu, Lucreţia Anghel, I. Chiscop, Anamaria Ciubara
{"title":"Study on the Impact of Depression on the Quality of Life of Patients With Psoriasis","authors":"Roxana-Cristina Oltenacu, Gabriela Stoleriu, Lucreţia Anghel, I. Chiscop, Anamaria Ciubara","doi":"10.18662/brain/15.1/568","DOIUrl":null,"url":null,"abstract":"Introduction: Psoriasis is a chronic condition with a strong impact on the daily life of patients, especially on relationship life. This paper aims to clarify the impact of depression on the quality of life of patients with moderate psoriasis. Methods: A cross-sectional study was conducted on 16 participants with psoriasis from April to May 2023. Patients with psoriasis vulgaris completed self-administered questionnaires which include demographic characteristics, Hamilton Depression Rating Scale (HAM-D) and Dermatological Life Quality Index (DLQI). Data were collected both physically, during periodic checks and online by email. Only 16 patients met the eligibility criteria for study entry. All patients included in the study had moderate psoriasis vulgaris. Exclusion criteria for participation in the study was: current use of psychotropic medications. severe comorbidities or chronic medical conditions and visual, auditory, linguistic, or cognitive impairments. Results: After completed the Hamilton Depression Rating Scale (HAM-D) half of them 8 (50%) had a score lower than 8 (minimal depression) and the other half  8 (50%) between 8-16 (mild depression). 14 (87.5%) of the participants had a DLQI score of more than 10, indicating severe impairment in their quality of life. The results obtained showed a positive correlation between Dermatological Life Quality Index (DLQI) andHamilton Depression Rating Scale (HAM-D). Conclusions: Depressive manifestations significantly influence the quality of life of psoriasis patients analyzed. A multidisciplinary approach in treating the patient with psoriasis is indispensable because it is not only necessary to manage a disease or a \"case\", but also to manage a patient. \n ","PeriodicalId":504804,"journal":{"name":"BRAIN. Broad Research in Artificial Intelligence and Neuroscience","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BRAIN. Broad Research in Artificial Intelligence and Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18662/brain/15.1/568","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Psoriasis is a chronic condition with a strong impact on the daily life of patients, especially on relationship life. This paper aims to clarify the impact of depression on the quality of life of patients with moderate psoriasis. Methods: A cross-sectional study was conducted on 16 participants with psoriasis from April to May 2023. Patients with psoriasis vulgaris completed self-administered questionnaires which include demographic characteristics, Hamilton Depression Rating Scale (HAM-D) and Dermatological Life Quality Index (DLQI). Data were collected both physically, during periodic checks and online by email. Only 16 patients met the eligibility criteria for study entry. All patients included in the study had moderate psoriasis vulgaris. Exclusion criteria for participation in the study was: current use of psychotropic medications. severe comorbidities or chronic medical conditions and visual, auditory, linguistic, or cognitive impairments. Results: After completed the Hamilton Depression Rating Scale (HAM-D) half of them 8 (50%) had a score lower than 8 (minimal depression) and the other half  8 (50%) between 8-16 (mild depression). 14 (87.5%) of the participants had a DLQI score of more than 10, indicating severe impairment in their quality of life. The results obtained showed a positive correlation between Dermatological Life Quality Index (DLQI) andHamilton Depression Rating Scale (HAM-D). Conclusions: Depressive manifestations significantly influence the quality of life of psoriasis patients analyzed. A multidisciplinary approach in treating the patient with psoriasis is indispensable because it is not only necessary to manage a disease or a "case", but also to manage a patient.  
抑郁症对银屑病患者生活质量影响的研究
导言银屑病是一种慢性疾病,对患者的日常生活,尤其是感情生活有很大影响。本文旨在阐明抑郁症对中度银屑病患者生活质量的影响。研究方法于 2023 年 4 月至 5 月对 16 名银屑病患者进行了横断面研究。寻常型银屑病患者填写了自填问卷,其中包括人口统计学特征、汉密尔顿抑郁量表(HAM-D)和皮肤病生活质量指数(DLQI)。数据收集方式有两种,一种是通过身体检查,另一种是通过电子邮件在线收集。只有 16 名患者符合研究入选标准。所有参与研究的患者均患有中度寻常型银屑病。参加研究的排除标准是:目前正在使用精神药物;严重的合并症或慢性疾病;视觉、听觉、语言或认知障碍。研究结果完成汉密尔顿抑郁评定量表(HAM-D)后,其中一半 8 人(50%)的得分低于 8 分(轻度抑郁),另一半 8 人(50%)的得分在 8-16 分之间(轻度抑郁)。有 14 人(87.5%)的 DLQI 得分超过 10 分,表明他们的生活质量受到严重影响。结果显示,皮肤病生活质量指数(DLQI)与汉密尔顿抑郁量表(HAM-D)之间存在正相关。结论是抑郁表现严重影响了银屑病患者的生活质量。治疗银屑病患者的多学科方法是不可或缺的,因为这不仅是管理疾病或 "病例 "的需要,也是管理患者的需要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信